September 23, 2021
This story features GenEdit, a former QB3 Garage@Berkeley company. The incubator space in Stanley Hall features more than 800 square feet of laboratory space for startup companies. Kunwoo Lee was a…
September 16, 2021
Elçin Ünal and Gloria Brar, associate professors of molecular and cell biology, have been named 2021 Innovation Fund investigators by the Pew Charitable Trusts.
September 07, 2021
UC Berkeley’s Ting Xu and her students have come up with one solution for the global problem of single-use plastics: embed enzymes in the plastic, so that once the bag or cup is no longer wanted, it will self-destruct with a little heat and water.
August 09, 2021
In efforts to develop a COVID-19 diagnostic test faster than qRT-PCR, a research team led by QB3-Berkeley affiliates Jennifer Doudna, David Savage, and Patrick Hsu have combined two different types of CRISPR enzymes to create an assay that can detect small amounts of viral RNA in less than an hour.
July 28, 2021
Scientific interventions for tackling humanity’s addiction to plastic are hoping to make breakthroughs that could help restore the environment in a post-pandemic future.
July 26, 2021
In January 2020, Marco Lobba had developed a new way of fusing proteins together that he thought could help treat autoimmune diseases like lupus, multiple sclerosis or Type 1 diabetes. A year later, he and Geo Guillen remotely launched Catena Biosciences, turning the potentially lifesaving idea into a successful company.
July 21, 2021
Chemical biologists in the Wenjun Zhang Lab at the University of California, Berkeley, have discovered compound mutanofactin-697. This compound is crucial in the development of cavities induced by Streptococcus mutans and may serve as a target in the prevention and treatment of dental caries.
June 24, 2021
QB3-Berkeley affiliate and public health expert Lee Riley addresses state reopening plans, the effectiveness of the COVID-19 vaccine against variants, health inequities that have been exposed by the pandemic, and moving forward to “a new type of normal.”